Jagielska B, Czubek A, Talasiewicz K, Twarowski A, Rutkowski P, Krzakowski M, Saetre B, Malecki M. Assessment of efficacy of trastuzumab (Herceptin) comprising adjuvant therapy of HER2+ breast cancer patients determined based upon statistical analysis of overall survival (OS) and disease-free survival (PFS) . MCTM [Internet]. 2023 Mar. 27 [cited 2024 Nov. 13];6(1):37-49. Available from: https://riverpublishersjournal.com/index.php/MCTM/article/view/211